Back to search

Article

Intracellular targeting with engineered proteins

2016-08-10

Abstract excerpt

If the isolation, production, and clinical use of insulin marked the inception of the age of biologics as therapeutics, the convergence of molecular biology and combinatorial engineering techniques marked its coming of age. The first wave of recombinant protein-based drugs in the 1980s demonstrated emphatically that proteins could be engineered, formulated, and employed for clinical advantage. Yet despite the succ...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
0c11d74c-3ba7-5ca9-bfc4-519d868a4c06
DOI
10.12688/f1000research.8915.1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intracellular targeting with engineered proteinsDOI 10.12688/f1000research.8915.1
Select a neighboring publication to make it the new centre.